TYRX Receives FDA Clearance for Use of Antibacterial Envelope With Spinal Cord Neuromodulators

TYRX announced that it has received FDA clearance for marketing the AIGISRx N Antibacterial Envelope for use with spinal cord neuromodulators.

Advertisement

This comes soon after FDA clearance of the envelope for use with vagus nerve stimulators.

 

The AIGISRx N Antibacterial Envelope is intended to hold a spinal cord neuromodulator or vagus nerve stimulator securely in place to provide a stable environment when implanted in the body.

More Articles on Supply Chain:

5 Ways Materials Management Information Systems Can Improve Surgery Center Supply Chain
Mazor Robotics’ Sells Renaissance Spine System to Lawnwood Regional Medical Center
Alphatec Spine Posts $14.5M Q3 Loss After PurGen Device Discontinuation

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • Stryker CEO Kevin Lobo’s total compensation was $21.4 million in 2025, according to a recent Securities and Exchange Commission proxy filing.…

  • John DeFord, PhD, is stepping down from Globus Medical’s board of directors, according to a March 23 news release. His…

Advertisement

Comments are closed.